Aquablation in Benign Prostatic Hyperplasia in Canada

Launched by CAN-AM HIFU INC. · Dec 9, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called Aquablation for men with a condition known as Benign Prostatic Hyperplasia (BPH), which is when the prostate gland becomes enlarged and can cause urinary problems. The goal of the trial is to see how effective Aquablation is for Canadian patients suffering from this condition. Men between the ages of 18 and 74 who have been diagnosed with BPH and are considered suitable candidates for Aquablation therapy may be eligible to participate.

If you or a loved one decides to take part in this study, you will need to fill out some questionnaires to help researchers understand your experience with the treatment. Before joining, you'll be asked to give your consent, meaning you'll agree to participate and understand what the study involves. The trial is currently recruiting participants, and it’s important to know that anyone with certain health issues or who may not be able to follow the study's requirements will not be able to join. This is a great opportunity to contribute to important research that could help improve treatment for BPH.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Primary diagnosis of Benign Prostate Hypertrophy (BPH)
• • Male subjects of ≥ 18 years of age
• • Candidate for Aquablation therapy as per clinical decision of Investigator
• • Willing and able to accurately complete questionnaires
• • Willing and able to provide signed and dated informed consent
• Exclusion Criteria:
• • Characteristics indicating a poor compliance with study protocol requirements.
• • Disease or other health condition that is not suitable for this study.
• • Unable or unwilling to provide signed informed consent.